Brodies advised the management team of Crawford Scientific Holdings Ltd, a leading supplier of chromatography products and analytical services to the laboratory research and testing sectors, during the acquisition of the business by Limerston Capital Partners. 

Crawford Scientific was sold for an undisclosed sum, with its investor Maven Capital Partners achieving a full exit and the management team of Crawford Scientific rolling over some of their equity.

Neil Burgess from Brodies represented Crawford Scientific’s management team during the acquisition, negotiating the terms of their rollover and shareholder arrangements with their new partner, Limerston Capital Partners.